MedPath

Afaxys Pharma, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

EContra One-Step

Approval Date
Apr 8, 2025
FDA

Tri-VyLibra

Approval Date
Feb 2, 2024
FDA

Jasmiel

Approval Date
Dec 16, 2023
FDA

Tarina Fe 1/20 EQ

Approval Date
Nov 21, 2023
FDA

TARINA 24 FE

Approval Date
Nov 1, 2023
FDA

Chateal EQ

Approval Date
Sep 2, 2023
FDA

Aubra EQ

Approval Date
Sep 1, 2023
FDA

Lidocaine Hydrochloride

Approval Date
Jul 14, 2023
FDA

Tri-VyLibra Lo

Approval Date
May 4, 2023
FDA

VyLibra

Approval Date
Apr 13, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.